TScan Therapeutics Named a Top Place to Work by The Boston Globe for Three Consecutive Years

Company Overview - TScan Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing T cell receptor (TCR)-engineered T cell (TCR-T) therapies for cancer treatment [5] - The company's lead TCR-T therapy candidates are aimed at treating hematologic malignancies and preventing relapse after allogeneic hematopoietic cell transplantation [5] - TScan is expanding its ImmunoBank, a repository of therapeutic TCRs, to provide customized multiplex TCR-T therapies for various cancers [5] Recognition and Workplace Culture - TScan has been recognized as one of the Top Places to Work in Massachusetts for the third consecutive year, reflecting its employee-centric values and exceptional workplace culture [3][2] - The recognition is based on a survey conducted by Energage, which collected confidential feedback from nearly 68,000 employees across 323 organizations in Massachusetts [3][2] - The survey evaluates employee opinions on various aspects such as company direction, management, work environment, and benefits [2] Leadership Statements - The CEO of TScan, Gavin MacBeath, emphasized the company's commitment to advancing its clinical-stage pipeline and acknowledged the hard work of the team in creating a positive workplace culture [3] - Ann Hargraves, Senior VP of Human Resources, highlighted the organization's progress over the past five years and the importance of a committed and unified team [3]